ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 813

Citrulline Specific CD4+ T Cells Exhibit a Th1 Memory Phenotype In Rheumatoid Arthritis Subjects and Their Ex Vivo Frequency Is Influenced By Both Disease Duration and Biologic Therapy

Eddie James1, Mary Rieck2, Jennifer Pieper3, John Gebe4, Betty Yue4, Megan Tatum5, Charlotta Sandin6, Lars Klareskog7, Vivianne Malmström8 and Jane Buckner9, 1Benaroya Research Institute, Seattle, WA, 2Translational Research Program, Benaroya Research Institute, Seattle, WA, 3Department of Medicine, Karolinska Institutet, Rheumatology Unit, Stockholm, Sweden, 4Diabetes Research Program, Benaroya Research Institute at Virginia Mason, Seattle, WA, 5Translational Research Program, Benaroya Research Institute at Virginia Mason, Seattle, WA, 6Department of Medicine, Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden, 7Rheumatology Unit, Department of Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, 8Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden, 9Translational Research Program, Benaroya Research Institute, Seattle, WA 98101, USA,, Seattle, WA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Biomarkers, citrullination, flow cytometry and rheumatoid arthritis (RA), T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Autoantibodies and Citrullinated Proteins

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Rheumatoid arthritis is thought to be a T cell mediated disease, based on its strong association with HLA class II alleles, clinical responsiveness to T cell directed therapies and the presence of CD4 T cells in rheumatoid joints. Understanding the character and antigen specificity of auto-reactive T cell responses in RA has been elusive, in part due to the limited identification of the most relevant epitopes and inability to interrogate responses directly ex vivo.  The presence of ACPA in the serum of patients and association of these antibodies with HLA-DR4 alleles provides a clue to the specificity of pathogenic T cells and implicates their probable importance in the development and progression of RA.

Methods:

We developed a panel of HLA-DR0401 tetramers, selecting citrullinated peptides from four different synovial antigens and verifying their immunogenicity in HLA-DR4 transgenic mice.  This panel of tetramers was used to directly examine the frequency and cell surface phenotype of T cells specific for citrullinated peptides in subjects with DR0401 haplotypes using an ex vivo magnetic enrichment procedure. 

Results:

Citrullinated-antigen specific CD4 T cells were detectable in peripheral blood samples from both healthy subjects and RA patients.  In comparison to healthy subjects, RA patients had significantly higher frequencies of citrullinated-antigen specific T cells (p=0.0069) and a greater proportion of these cells displayed a TH1 memory phenotype (p<0.0001).  Among RA subjects the frequency of citrullinated-antigen specific T cells was significantly higher within the first 5 years after disease onset (p=0.0018) and was decreased among patients on biologic therapies (p<0.0001) and this difference was seen irrespective of disease duration, indicating an independent effect.

Conclusion:

This study represents the first evidence that the frequency and phenotype of citrullinated-antigen specific T cells vary with respect to important disease parameters and are therefore a potential biomarker in at risk individuals and subjects with RA.  These findings link the presence of ACPA in patient serum with T cells specific to citrullinated epitopes and suggest that the pathogenic T cells in established RA are of a Th1 lineage.


Disclosure:

E. James,
None;

M. Rieck,
None;

J. Pieper,
None;

J. Gebe,
None;

B. Yue,
None;

M. Tatum,
None;

C. Sandin,
None;

L. Klareskog,

No own commercial interests,

2;

V. Malmström,
None;

J. Buckner,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/citrulline-specific-cd4-t-cells-exhibit-a-th1-memory-phenotype-in-rheumatoid-arthritis-subjects-and-their-ex-vivo-frequency-is-influenced-by-both-disease-duration-and-biologic-therapy/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology